The NASDAQ Biotechnology Index is a
stock market index made up of securities of
NASDAQ-listed companies classified according to the
Industry Classification Benchmark The Industry Classification Benchmark (ICB) is an industry classification taxonomy launched by Dow Jones and FTSE in 2005 and now used by FTSE International and STOXX. It is used to segregate markets into sectors within the macroeconomy. The I ...
as either the
Biotechnology
Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used ...
or the
Pharmaceutical industry
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate symptoms. ...
.
A list of the 213 components of the index is publishe
online
Criteria
In order to remain included within the index, the components must meet the following criteria:
* The security U.S. listing must be exclusively on the NASDAQ National Market (unless the security was dually listed on another U.S. market prior to January 1, 2004 and has continuously maintained such listing).
* The issuer of the security must be classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.
* The security may not be issued by an issuer currently in bankruptcy proceedings.
* The security must have a market capitalization of at least $200 million.
* The security must have an average daily trading volume of at least 100,000 shares.
* The issuer of the security may not have entered into a definitive agreement or other arrangement which would likely result in the security no longer being Index.
* The issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn.
* The issuer of the security must have "seasoned" on NASDAQ or another recognized market for at least 6 months; in the case of spin-offs, the operating history of the spin-off will be considered.
Investing in the index
This index is tracked by several exchange-traded funds, the most liquid of which is the
iShares
iShares is a collection of exchange-traded funds (ETFs) managed by BlackRock, which acquired the brand and business from Barclays in 2009. The first iShares ETFs were known as World Equity Benchmark Shares (WEBS) but have since been rebranded. ...
Nasdaq Biotechnology ().
[
]
References
External links
Nasdaq Biotechnology Index components
Yahoo! Finance page for NASDAQ Biotechnology
{{Nasdaqomx
Nasdaq
American stock market indices
Stock market indices by industry
Biotechnology in the United States